The identification of irisin in human cerebrospinal fluid: Influence of adiposity, metabolic markers, and gestational diabetes

American Journal of Physiology - Endocrinology and Metabolism

Volumn 306, Issue 5, 2014, Pages

  Piya, Milan K ^a,b   Harte, Alison L ^a   Sivakumar, Kavitha ^a   Tripathi, Gyanendra ^a   Voyias, Philip D ^a   James, Sean ^b   Sabico, Shaun ^a,c   Al Daghri, Nasser M ^c   Saravanan, Ponnusamy ^a   Barber, Thomas M ^a,b   Kumar, Sudhesh ^a,b   Vatish, Manu ^d   McTernan, Philip G ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Gestational diabetes mellitus; Irisin; Leptin; Obesity

Indexed keywords

GLUCOSE; INSULIN; IRISIN; LEPTIN; LIPID; METFORMIN; NEUROPEPTIDE Y; PEPTIDE HORMONE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD LEVEL; BODY MASS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CESAREAN SECTION; CORD SERUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL SERUM; METABOLIC PARAMETERS; METABOLIC REGULATION; NERVE CELL; NEWBORN; OBESITY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROGENY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; METABOLISM; PHYSIOLOGY; PREGNANCY;

GESTATIONAL DIABETES MELLITUS; IRISIN; LEPTIN; OBESITY;

ADIPOSITY; ADULT; BIOLOGICAL MARKERS; DIABETES, GESTATIONAL; FEMALE; FIBRONECTINS; HUMANS; HYPOTHALAMUS; NEURONS; NEUROPEPTIDE Y; OBESITY; PREGNANCY;

EID: 84893901804     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00308.2013     Document Type: Article

References (35)

1. Al-Daghri NM, Alkharfy KM, Rahman S, Amer OE, Vinodson B, Sabico S, Piya MK, Harte AL, McTernan PG, Alokail MS, Chrousos GP. Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects. Eur J Clin Invest. In press.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.
3. Aydin S, Kuloglu T. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus. Peptides 47: 66-70, 2013.
4. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481: 463-468, 2012.
5. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK, Park KG. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 100: 96-101, 2013.
6. Coppari R, Bjorbaek C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov 11: 692-708, 2012.
7. Corp ES, Conze DB, Smith F, Campfield LA. Regional localization of specific [125I]leptin binding sites in rat forebrain. Brain Res 789: 40-47, 1998.
8. Cowley MA, Pronchuk N, Fan W, Dinulescu DM, Colmers WF, Cone RD. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24: 155-163, 1999.
9. Dun SL, Lyu RM, Chen YH, Chang JK, Luo JJ, Dun NJ. Irisinimmunoreactivity in neural and non-neural cells of the rodent. Neuroscience 240: 155-162, 2013.
10. Giapros V, Evagelidou E, Challa A, Kiortsis D, Drougia A, Andronikou S. Serum adiponectin and leptin levels and insulin resistance in children born large for gestational age are affected by the degree of overweight. Clin Endocrinol (Oxf) 66: 353-359, 2007.
11. Hashemi MS, Ghaedi K, Salamian A, Karbalaie K, Emadi-Baygi M, Tanhaei S, Nasr-Esfahani MH, Baharvand H. Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells. Neuroscience 231: 296-304, 2013.
12. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61: 1725-1738, 2012.
13. Kelly DP. Medicine. Irisin, light my fire. Science 336: 42-43, 2012.
14. Kos K, Harte AL, da Silva NF, Tonchev A, Chaldakov G, James S, Snead DR, Hoggart B, O'Hare JP, McTernan PG, Kumar S. Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab 92: 1129-1136, 2007.
15. Kusminski CM, McTernan PG, Schraw T, Kos K, O'Hare JP, Ahima R, Kumar S, Scherer PE. Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum. Diabetologia 50: 634-642, 2007.
16. Lecker SH, Zavin A, Cao P, Arena R, Allsup K, Daniels KM, Joseph J, Schulze PC, Forman DE. Expression of the Irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail 5: 812-818, 2012.
17. Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, Tavintharan S, Sum CF, Lim SC. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 27: 365-369, 2013.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
19. Merino B, Diez-Fernandez C, Ruiz-Gayo M, Somoza B. Choroid plexus epithelial cells co-express the long and short form of the leptin receptor. Neurosci Lett 393: 269-272, 2006.
20. Moon HS, Dincer F, Mantzoros CS. Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism 62: 1131-1136, 2013.
21. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Manuel-Fernández-Real J. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98: E769-E778, 2013.
22. Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, Tsoukas M, Geladari EV, Young Huh J, Dincer F, Davis CR, Crowell JA, Mantzoros CS. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab 98: 4899-4907, 2013.
23. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8: 457-465, 2012.
24. Pekkala S, Wiklund P, Hulmi JJ, Ahtiainen JP, Horttanainen M, Pöllänen E, Mäkelä KA, Kainulainen H, Häkkinen K, Nyman K, Alen M, Herzig KH, Cheng S. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol 591: 5393-5400, 2013.
25. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Crujeiras AB, Seoane LM, Casanueva FF, Pardo M. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 8: e60563, 2013.
26. Savino F, Liguori SA, Oggero R, Silvestro L, Miniero R. Maternal BMI and serum leptin concentration of infants in the first year of life. Acta Paediatr 95: 414-418, 2006.
27. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2: 589-593, 1996.
28. Sharma N, Castorena CM, Cartee GD. Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines (Abstract). Nutr Metab (Lond) 9: 90, 2012.
29. Spiegelman BM. Regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes 62: 1774-1782, 2013.
30. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 39: 125-130, 2013.
31. Swick AG, Orena S, O'Connor A. Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism 62: 1070-1073, 2013.
32. Wiedenhoft A, Muller C, Stenger R, Blum WF, Fusch C. Lack of sex difference in cerebrospinal fluid (CSF) leptin levels and contribution of CSF/plasma ratios to variations in body mass index in children. J Clin Endocrinol Metab 84: 3021-3024, 1999.
33. Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, Lin JD, Greenberg ME, Spiegelman BM. Exercise induces hippocampal BDNF through a PGC-1_/FNDC5 pathway. Cell Metab 18: 649-659, 2013.
34. Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, Huang K, Tu H, van Marken Lichtenbelt WD, Hoeks J, Enerback S, Schrauwen P, Spiegelman BM. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150: 366-376, 2012.
35. Zlokovic BV, Jovanovic S, Miao W, Samara S, Verma S, Farrell CL. Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. Endocrinology 141: 1434-1441, 2000.